Palforzia for peanut allergy: Panacea or predicament
- PMID: 35467777
- DOI: 10.1111/cea.14145
Palforzia for peanut allergy: Panacea or predicament
References
REFERENCES
-
- Schofield AT. A case of egg poisoning. Lancet. 1908;171(4410):716.
-
- Anagnostou K, Islam S, King Y, et al. Assessing the efficacy of oral immunotherapy for the desensitisation of peanut allergy in children (STOP II): a phase 2 randomised controlled trial. Lancet. 2014;383(9925):1297-1304.
-
- Anagnostou K, Clark A, King Y, Islam S, Deighton J, Ewan P. Efficacy and safety of high-dose peanut oral immunotherapy with factors predicting outcome. Clin Exp Allergy. 2011;41(9):1273-1281.
-
- PALISADE Group of Clinical Investigators. AR101 oral immunotherapy for peanut allergy. N Engl J Med. 2018;379(21):1991-2001.
-
- Chu DK, Wood RA, French S, et al. Oral immunotherapy for peanut allergy (PACE): a systematic review and meta-analysis of efficacy and safety. Lancet. 2019;393(10187):2222-2232.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources